Samuel D. Banister

Also affiliated with Io Therapeutics (United States)

MedicinePharmacology, Toxicology and PharmaceuticsNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome”.

Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome

PLoS ONE(2023)10.1371/journal.pone.0280842

N/A

0DataRank · unranked

3 citations

Dilara Bahceci, Nicole A. Hawkins, Declan Everett‐Morgan, Samuel D. Banister, Jennifer A. Kearney +2 more